Clinical trial
A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects
NCT06837155 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects
- Lead sponsor
- Taisho Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 3, 2025
- Completion date
- May 26, 2025
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers